Use of quinoline derivatives with anti-integrase effect and applications thereof
US7479497B2 · kind B2 · utility
1Cited by
1References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 15, 2003 |
| Grant date | Jan 20, 2009 |
| Priority date | — |
| Expiry date | Jun 1, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of 8-hydroxyquinoline 7-carboxylic acid derivatives in order to produce integrase-inhibiting medicaments, capable of blocking viral replication in the stages preceding integration, and if appropriate at the level of this integration stage, these medicaments being usable for the treatment of retroviral pathologies, in particular for the treatment of AIDS.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.